Cytokinetics, Incorporated (BIT:1CYTK)

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2013 - 2020
Research and Development Revenue	7.86M	3.47M	Log In	Log In	Log In	Upgrade
License Revenue	-	-	Log In	Log In	Log In	Upgrade
Milestone Revenue	-	15.00M	Log In	Log In	Log In	Upgrade
Realization of Revenue Participation Right Purchase Agreement	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	7.86M	18.47M	Log In	Log In	Log In	Upgrade